thalidomide bms (previously thalidomide celgene)
bristol-myers squibb pharma eeig - thalidomid - multiples myelom - immunsuppressiva - thalidomide bms in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged >/= 65 years or ineligible for high dose chemotherapy. thalidomide bms is prescribed and dispensed according to the thalidomide celgene pregnancy prevention programme (see section 4.
lenalidomide accord
accord healthcare s.l.u. - lenalidomid - multiples myelom - immunsuppressiva - multiple myelomalenalidomide accord as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide accord as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) ist indiziert für die behandlung erwachsener patienten mit zuvor unbehandeltem multiplen myelom, die nicht die voraussetzungen für eine transplantation. lenalidomid accord in kombination mit dexamethason ist indiziert für die behandlung des multiplen myeloms bei erwachsenen patienten, die erhalten haben, mindestens eine vorherige therapie. follicular lymphomalenalidomide accord in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).
lenalidomide teva 2,5 mg hartkapsel
teva - lenalidomidhydrochlorid hydrat - hartkapsel - 2,5 mg - lenalidomidhydrochlorid hydrat 3.025 mg - lenalidomide
lenalidomide teva 5 mg hartkapsel
teva - lenalidomidhydrochlorid hydrat - hartkapsel - 5 mg - lenalidomidhydrochlorid hydrat 6.05 mg - lenalidomide
lenalidomide teva 7,5 mg hartkapsel
teva - lenalidomidhydrochlorid hydrat - hartkapsel - 7,5 mg - lenalidomidhydrochlorid hydrat 9.075 mg - lenalidomide
lenalidomide teva 10 mg hartkapsel
teva - lenalidomidhydrochlorid hydrat - hartkapsel - 10 mg - lenalidomidhydrochlorid hydrat 12.1 mg - lenalidomide
lenalidomide teva 15 mg hartkapsel
teva - lenalidomidhydrochlorid hydrat - hartkapsel - 15 mg - lenalidomidhydrochlorid hydrat 18.15 mg - lenalidomide
lenalidomide teva 20 mg hartkapsel
teva - lenalidomidhydrochlorid hydrat - hartkapsel - 20 mg - lenalidomidhydrochlorid hydrat 24.2 mg - lenalidomide
lenalidomide teva 25 mg hartkapsel
teva - lenalidomidhydrochlorid hydrat - hartkapsel - 25 mg - lenalidomidhydrochlorid hydrat 30.25 mg - lenalidomide
thalidomide lipomed
lipomed gmbh - thalidomid - multiples myelom - immunsuppressiva - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.